GLOBAL NON-INVASIVE PRENATAL TESTING MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023

Jan 2019 115

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

NIPT (noninvasive prenatal testing) is a blood test used to screen for Down syndrome and a few other chromosomal conditions. You can have NIPT at 10 weeks of pregnancy or later. (You can also find out your baby's sex when you have this test.) ... NIPT is a screening test, not a diagnostic test.

Scope of the Report:
This report studies the Non-invasive Prenatal Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Non-invasive Prenatal Testing market by product type and applications/end industries.
The invasive methods of prenatal testing can cause miscarriages and are painful. This resulted in the development of non-invasive prenatal testing (NIPT) through advancements in genomic sciences and bioinformatic analytical tools. NIPT was introduced in the year 2011. This enabled physicians to carry out a safe screening and detection of chromosomal abnormalities in fetuses.
The global Non-invasive Prenatal Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Non-invasive Prenatal Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
- PerkinElmer
- Roche
- Sequenom
- BGI Genomics
- Illumina
- LifeCodexx
- Natera

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- First trimester
- Second trimester
- Third trimester
- Post-term

Market Segment by Applications, can be divided into
- Hospital
- Laboratory

Table of Contents

Related reports :

(Jan 19)

C-reactive protein (CRP) is an annular (ring-shaped), pentameric protein found in blood plasma, whose levels rise in response to inflammatio...

(Jan 19)

Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection. ...

(Jan 19)

POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. Scope of the Report: This...

(Jan 19)

Orthodontics is the branch of dentistry that deals with the prevention and correction of irregular teeth and jaws as by means of braces or o...

(Jan 19)

Paper diagnostics are paper-based diagnostic tests performed for the detection of various infectious diseases and food quality monitoring....

(Jan 19)

A periodontal disease is an infection of the tissues in the mouth that results in detachment of teeth from the gums. Scope of...

GLOBAL NON-INVASIVE PRENATAL TESTING MARKET 2018 BY MANUFACTURERS, COUNTRIES, TYPE AND APPLICATION, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy